Skip to main content

The latest developments on the gene therapy frontier

Gene therapy is once again at the forefront of biomedical research, catalyzed by advances in safer delivery of genes to cells. Science may also move quickly past gene replacement therapy to gene editing via CRISPR and other methods, an approach in which the unknowns are even greater and clinical results are just beginning to emerge.

included in this trendline
  • A rare biotech IPO raises $175M for Prime Medicine and its gene editing technology
  • With $2.8M gene therapy, Bluebird sets new bar for US drug pricing
  • ‘We have to find a way’: FDA seeks solutions to aid bespoke gene therapy
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.